Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system.

Yamaguchi T, Machida N, Morizane C, Kasuga A, Takahashi H, Sudo K, Nishina T, Tobimatsu K, Ishido K, Furuse J, Boku N, Okusaka T.

Cancer Sci. 2014 Jun 28. doi: 10.1111/cas.12473. [Epub ahead of print]

PMID:
24975505
[PubMed - as supplied by publisher]
2.

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma.

Ikeda M, Shiina S, Nakachi K, Mitsunaga S, Shimizu S, Kojima Y, Ueno H, Morizane C, Kondo S, Sakamoto Y, Asaoka Y, Tateishi R, Koike K, Arioka H, Okusaka T.

Invest New Drugs. 2014 May 15. [Epub ahead of print]

PMID:
24829073
[PubMed - as supplied by publisher]
3.

A retrospective analysis of factors associated with selection of end-of-life care and actual place of death for patients with cancer.

Kondo S, Shimazu T, Morizane C, Hosoi H, Okusaka T, Ueno H.

BMJ Open. 2014 May 2;4(5):e004352. doi: 10.1136/bmjopen-2013-004352.

PMID:
24793245
[PubMed]
Free PMC Article
4.

Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial.

Terazawa T, Kondo S, Hosoi H, Morizane C, Shimizu S, Mitsunaga S, Ikeda M, Ueno H, Okusaka T.

BMC Cancer. 2014 Apr 30;14:301. doi: 10.1186/1471-2407-14-301.

PMID:
24779747
[PubMed - in process]
Free PMC Article
5.

Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma.

Ikeda M, Ohkawa S, Okusaka T, Mitsunaga S, Kobayashi S, Morizane C, Suzuki I, Yamamoto S, Furuse J.

Cancer Sci. 2014 Apr;105(4):455-62. doi: 10.1111/cas.12368. Epub 2014 Mar 25.

PMID:
24521523
[PubMed - indexed for MEDLINE]
6.

Twenty-six cases of advanced ampullary adenocarcinoma treated with systemic chemotherapy.

Shoji H, Morizane C, Hiraoka N, Kondo S, Ueno H, Ohno I, Shimizu S, Mitsunaga S, Ikeda M, Okusaka T.

Jpn J Clin Oncol. 2014 Apr;44(4):324-30. doi: 10.1093/jjco/hyt237. Epub 2014 Jan 30.

PMID:
24482413
[PubMed - indexed for MEDLINE]
7.

Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma.

Hagihara A, Ikeda M, Ueno H, Morizane C, Kondo S, Nakachi K, Mitsunaga S, Shimizu S, Kojima Y, Suzuki E, Katayama K, Imanaka K, Tamai C, Inaba Y, Sato Y, Kato M, Okusaka T.

Cancer Sci. 2014 Mar;105(3):354-8. doi: 10.1111/cas.12353. Epub 2014 Feb 18.

PMID:
24438504
[PubMed - indexed for MEDLINE]
8.

Emerging drugs for biliary cancer.

Okusaka T, Ojima H, Morizane C, Ikeda M, Shibata T.

Expert Opin Emerg Drugs. 2014 Mar;19(1):11-24. doi: 10.1517/14728214.2014.870553. Epub 2013 Dec 20.

PMID:
24354562
[PubMed - in process]
9.

[Chemotherapy for gallbladder cancer].

Okusaka T, Morizane C, Ikeda M.

Nihon Shokakibyo Gakkai Zasshi. 2013 Aug;110(8):1415-27. Review. Japanese. No abstract available.

PMID:
23912001
[PubMed - indexed for MEDLINE]
10.

Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma.

Kondo S, Ueno H, Hosoi H, Hashimoto J, Morizane C, Koizumi F, Tamura K, Okusaka T.

Br J Cancer. 2013 Aug 6;109(3):739-46. doi: 10.1038/bjc.2013.348. Epub 2013 Jul 4.

PMID:
23828517
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization.

Ikeda M, Mitsunaga S, Shimizu S, Ohno I, Takahashi H, Okuyama H, Kuwahara A, Kondo S, Morizane C, Ueno H, Satake M, Arai Y, Okusaka T.

J Gastroenterol. 2014 May;49(5):932-40. doi: 10.1007/s00535-013-0853-7. Epub 2013 Jun 23.

PMID:
23793266
[PubMed - in process]
12.

Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805).

Morizane C, Okusaka T, Mizusawa J, Takashima A, Ueno M, Ikeda M, Hamamoto Y, Ishii H, Boku N, Furuse J.

Cancer Sci. 2013 Sep;104(9):1211-6. doi: 10.1111/cas.12218. Epub 2013 Jul 25.

PMID:
23763511
[PubMed - indexed for MEDLINE]
13.

Gemcitabine in patients with intraductal papillary mucinous neoplasm with an associated invasive carcinoma of the pancreas.

Otsuka T, Morizane C, Nara S, Ueno H, Kondo S, Shimada K, Kosuge T, Ikeda M, Hiraoka N, Okusaka T.

Pancreas. 2013 Jul;42(5):889-92. doi: 10.1097/MPA.0b013e3182826f1f.

PMID:
23695798
[PubMed - indexed for MEDLINE]
14.

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.

Ito T, Okusaka T, Nishida T, Yamao K, Igarashi H, Morizane C, Kondo S, Mizuno N, Hara K, Sawaki A, Hashigaki S, Kimura N, Murakami M, Ohki E, Chao RC, Imamura M.

Invest New Drugs. 2013 Oct;31(5):1265-74. doi: 10.1007/s10637-012-9910-y. Epub 2012 Dec 27.

PMID:
23269537
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysis.

Mayahara H, Ito Y, Morizane C, Ueno H, Okusaka T, Kondo S, Murakami N, Morota M, Sumi M, Itami J.

BMC Cancer. 2012 Dec 20;12:609. doi: 10.1186/1471-2407-12-609.

PMID:
23256481
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma.

Shiba S, Kondo S, Ueno H, Morizane C, Ikeda M, Okusaka T.

Case Rep Oncol. 2012 Sep;5(3):515-9. doi: 10.1159/000342913. Epub 2012 Sep 28.

PMID:
23139664
[PubMed]
Free PMC Article
17.

Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapy.

Taniyama TK, Morizane C, Nakachi K, Nara S, Ueno H, Kondo S, Kosuge T, Shimada K, Esaki M, Ikeda M, Mitsunaga S, Kinoshita T, Konishi M, Takahashi S, Okusaka T.

Pancreatology. 2012 Sep-Oct;12(5):428-33. doi: 10.1016/j.pan.2012.07.016. Epub 2012 Jul 24.

PMID:
23127532
[PubMed - indexed for MEDLINE]
18.

Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial.

Ito T, Okusaka T, Ikeda M, Igarashi H, Morizane C, Nakachi K, Tajima T, Kasuga A, Fujita Y, Furuse J.

Jpn J Clin Oncol. 2012 Oct;42(10):903-11. Epub 2012 Jul 31.

PMID:
22859827
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer.

Kido H, Morizane C, Tamura T, Hagihara A, Kondo S, Ueno H, Okusaka T.

Jpn J Clin Oncol. 2012 Sep;42(9):845-50. doi: 10.1093/jjco/hys099. Epub 2012 Jul 10.

PMID:
22782959
[PubMed - indexed for MEDLINE]
Free Article
20.

Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy.

Kondo S, Ueno H, Hashimoto J, Morizane C, Koizumi F, Okusaka T, Tamura K.

BMC Cancer. 2012 Jun 25;12:268. doi: 10.1186/1471-2407-12-268.

PMID:
22731825
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk